As of 2025-09-18, the EV/EBITDA ratio of Gritstone Oncology Inc (GRTS) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GRTS's latest enterprise value is -8.76 mil USD. GRTS's TTM EBITDA according to its financial statements is -124.44 mil USD. Dividing these 2 quantities gives us the above GRTS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 13.6x | 13.0x |
| Forward P/E multiples | 19.2x - 43.4x | 31.3x |
| Fair Price | (46.99) - (33.23) | (54.25) |
| Upside | -146044.4% - -103291.3% | -168566.1% |
| Date | EV/EBITDA |